| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/10/2002 | WO2002002597A2 Peptide extended glycosylated polypeptides |
| 01/10/2002 | WO2002002596A2 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 01/10/2002 | WO2002002595A1 Amphipathic linear peptides and compositions containing same |
| 01/10/2002 | WO2002002593A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 01/10/2002 | WO2002002592A1 Memory-enhancing peptides and the use thereof |
| 01/10/2002 | WO2002002587A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | WO2002002556A2 AZA-BRIDGED-BICYCLIC AMINO ACID DERIVATIVES AS α4 INTEGRIN ANTAGONISTS |
| 01/10/2002 | WO2002002509A1 Compounds and compositions for delivering active agents |
| 01/10/2002 | WO2002002179A1 Microneedle for delivering a substance into the dermis |
| 01/10/2002 | WO2002002178A1 Needle for intradermal delivery of substances having penetration limiting means |
| 01/10/2002 | WO2002002148A2 Dual recombinant gene therapy compositions and methods of use |
| 01/10/2002 | WO2002002147A2 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 01/10/2002 | WO2002002144A1 Medicinal preparations for treating sex hormone-dependent diseases |
| 01/10/2002 | WO2002002143A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 01/10/2002 | WO2002002136A1 Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components |
| 01/10/2002 | WO2002002135A1 Preventives and remedies for diseases in association with demyelination |
| 01/10/2002 | WO2002002134A1 Use of secretin-receptor ligands in treatment of cystic fibrosis (cf) and chronic obstructive pulmonary disease (copd) |
| 01/10/2002 | WO2002002133A2 Peptide composition for treatment of periodontal diseases and prevention of skin aging |
| 01/10/2002 | WO2002002132A1 Chemokine conjugates |
| 01/10/2002 | WO2002002131A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/10/2002 | WO2002002121A2 Method for treatment and prevention of mastitis |
| 01/10/2002 | WO2002002110A1 Use of indole-3-acetic acid derivatives in medicine |
| 01/10/2002 | WO2002002053A2 Anticancer transgenic tomato |
| 01/10/2002 | WO2002002050A2 Prevention and treatment of mycoplasma-associated diseases |
| 01/10/2002 | WO2002002011A1 Dna encoding human serine protease d-g |
| 01/10/2002 | WO2002001956A1 Histidyl-proline diketopiperazine and method of use |
| 01/10/2002 | WO2001094636A8 Compositions, kits, and methods for identification and modulation of type i diabetes |
| 01/10/2002 | WO2001075084A3 Coffee mannanase |
| 01/10/2002 | WO2001074164A9 Methods of modulating hair growth |
| 01/10/2002 | WO2001070930A3 Growth factor binding molecules |
| 01/10/2002 | WO2001070813A3 REGULATION OF HUMAN GluR5-LIKE RECEPTOR |
| 01/10/2002 | WO2001070775A3 Wnt-1 related polypeptides, and nucleic acids encoding the same |
| 01/10/2002 | WO2001068830A8 Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same |
| 01/10/2002 | WO2001059071A3 Methods of preparing and using a viral vector library |
| 01/10/2002 | WO2001055307A3 Nucleic acids, proteins, and antibodies |
| 01/10/2002 | WO2001053349A3 Small cell lung cancer associated antigens and uses therefor |
| 01/10/2002 | WO2001051651A3 High expression and production of high-specific activity recombinant s-adenosyl homocysteinase (sahh) and improved assays for s-adenosylmethionine (sam) |
| 01/10/2002 | WO2001049831A3 Xylosyltransferase and isoforms thereof |
| 01/10/2002 | WO2001049708A3 Peptide ligands that mimic sensor kinases and inhibit response regulators |
| 01/10/2002 | WO2001046398A3 Aspartyl proteases |
| 01/10/2002 | WO2001045730A3 Tweak receptor |
| 01/10/2002 | WO2001044455A3 Antisense oligonucleotides for the inhibition of expression of type i procollagen |
| 01/10/2002 | WO2001043762A3 Polypeptide compositions with improved stability |
| 01/10/2002 | WO2001043691A3 Fragments and antagonists of heat shock protein 60 |
| 01/10/2002 | WO2001042466A3 Zvwf1: a member of the von willebrand factor type a domain superfamily |
| 01/10/2002 | WO2001042438A3 Leukolysin/mmp25/mt6-mmp |
| 01/10/2002 | WO2001042437A3 Histone deacetylase-8 proteins, nucleic acids, and methods of use |
| 01/10/2002 | WO2001041779A3 Combined use of glp-2 receptor agonist and chemotherapeutic agent in treatment |
| 01/10/2002 | WO2001040449A3 Cloning of a gene encoding an amino acid racemase from trypanosoma cruzi, and uses thereof |
| 01/10/2002 | WO2001040279A3 Hbv sequences |
| 01/10/2002 | WO2001040276A3 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 01/10/2002 | WO2001040270A3 A major neutralization site of hepatitis e virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies |
| 01/10/2002 | WO2001037896A3 Methods and compositions for administration of therapeutic reagents |
| 01/10/2002 | WO2001037850A3 Use of a milk protein hydrolysate in the treatment of diabetes |
| 01/10/2002 | WO2001036625A3 ANTISENSE OLIGONUCLEOTIDE SEQUENCES DERIVED FROM groEL AND groES AS INHIBITORS MICROORGANISMS |
| 01/10/2002 | WO2001036472A3 Compositions and methods for regulating tumor-associated antigen expression |
| 01/10/2002 | WO2001036452A3 Heteroclitic analogs of class i epitodes |
| 01/10/2002 | WO2001035810A3 Cancer immunotherapy and diagnosis using cytochrome p450 1b1 |
| 01/10/2002 | WO2001034633A3 Methods for treatment of human huntington's disease and methods of screening for active agents |
| 01/10/2002 | WO2001030971A3 Novel molecules and the card-related protein family and uses thereof |
| 01/10/2002 | WO2001030804A3 Salt form of a conjugate useful in the treatment of prostate cancer |
| 01/10/2002 | WO2001029217A3 Novel polypeptides and polynucleotides encoding same |
| 01/10/2002 | WO2001028593A3 Conjugates useful in the treatment of prostate cancer |
| 01/10/2002 | WO2001025410A3 DIAGNOSTIC PROBES AND THERAPEUTICS TARGETING uPA AND uPAR |
| 01/10/2002 | WO2001023430A3 Human chitinase immunoglobulin fusion proteins |
| 01/10/2002 | WO2001021191A3 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs |
| 01/10/2002 | WO2001012664A3 Notch receptor ligands and uses thereof |
| 01/10/2002 | WO2001011048B1 Therapeutic polypeptides and methods for using same |
| 01/10/2002 | WO2001000829A3 Human endogenous retrovirus in breast cancer |
| 01/10/2002 | WO2001000806A3 Dna's encoding proteins with signal peptides |
| 01/10/2002 | WO2001000661A3 Carnitine carrier related protein-1 |
| 01/10/2002 | WO2000066162A9 Mutant human cd80 and compositions for and methods of making and using the same |
| 01/10/2002 | WO2000055332A3 Human regulators of intracellular phosphorylation |
| 01/10/2002 | WO2000045800A3 Immunosurpressive effects of pteridine derivatives |
| 01/10/2002 | US20020004942 Transgenic plant that expresses luciferase; for use in the development of toys, foods, textiles and beverages that glow |
| 01/10/2002 | US20020004594 Phosphoramidates and methods therefor |
| 01/10/2002 | US20020004589 Detecting sensitivity to kidney disease |
| 01/10/2002 | US20020004586 Prion-binding activity in serum and proteins |
| 01/10/2002 | US20020004585 Antibody for use in the detection of preferential enzyme expression; for use as tool in treatment and detection of enzyme defects; for treatment autoimmune disease, inflammation, sepsis, diabetes, kidney defects and cancer |
| 01/10/2002 | US20020004584 HIV immune adjuvant therapy |
| 01/10/2002 | US20020004581 Polypeptide; for use in te diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004580 Polypeptide; for use in the diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004579 Preparation of a therapeutic composition |
| 01/10/2002 | US20020004555 Impact modified polyamide composition |
| 01/10/2002 | US20020004526 Medicament containing platinum complex compounds and the use thereof |
| 01/10/2002 | US20020004503 Viricides |
| 01/10/2002 | US20020004493 Interference with receptor binding; Alzheimer's disease |
| 01/10/2002 | US20020004492 Polypeptides; wound healing agent, antiinflammatory agent |
| 01/10/2002 | US20020004491 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 01/10/2002 | US20020004490 Antisense modulation of Fas mediated signaling |
| 01/10/2002 | US20020004489 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | US20020004488 Gene therapy |
| 01/10/2002 | US20020004485 Administering oligopeptide |
| 01/10/2002 | US20020004484 Topical anesthetic/opioid formulations and uses thereof |
| 01/10/2002 | US20020004483 Polypeptides, genetic engineering |
| 01/10/2002 | US20020004482 Treatment of acute lung injury and fibrosis with antagonists of avbeta6 |
| 01/10/2002 | US20020004481 Controlled release microencapsulated ngf formulation |
| 01/10/2002 | US20020004480 Using heptatocyte growth factor |
| 01/10/2002 | US20020004479 Biodegradable inserts |
| 01/10/2002 | US20020004478 Pharmaceutical formulations for igf/igfbp |